Jonathan Robert Hunt
CIK 1375410 · Chief Accounting Officer · last filed 2026-03-04
Jonathan Robert Hunt is a Chief Accounting Officer who has filed 20 SEC Form 4 insider transactions across 2 companies since 2007. The most recent filing, for CATX, was dated Mar 4, 2026. Across all open-market trades the lifetime net is +$234.9K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $176.4K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$176.4K
2
20
$234.9K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CATX | Chief Accounting Officer | 59,800 | $2.95 | $176.4K | $156.3K | 9 | 2026-03-04 |
| Perspective Therapeutics, Inc. (ISR) Delisted | Chief Financial Officer | 159,510 | $0.38 | $61.3K | $78.7K | 10 | 2022-12-05 |
Recent Filings
20 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-03-04 | CATX | Grant (A) | — | $0 | EDGAR |
| 2025-11-17 | CATX | Buy (P) | +11,000 | $22.3K | EDGAR |
| 2025-03-05 | CATX | Grant (A) | — | $0 | EDGAR |
| 2024-11-27 | CATX | Buy (P) | +12,829 | $49.0K | EDGAR |
| 2024-06-24 | CATX | Grant (A) | — | $0 | EDGAR |
| 2024-06-18 | CATX | Buy (P) | +1,800 | $17.7K | EDGAR |
| 2024-06-03 | CATX | Buy (P) | +25,006 | $35.0K | EDGAR |
| 2023-12-19 | CATX | Buy (P) | +125,000 | $32.3K | EDGAR |
| 2023-12-14 | CATX | Grant (A) | — | $0 | EDGAR |
| 2022-12-05 | Perspective Therapeutics, Inc. (ISR) Delisted | Buy (P) | +85,404 | $32.5K | EDGAR |